Results 171 to 180 of about 15,564 (249)

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro [PDF]

Omar Qureshi, Emma J. Sutton, Rosemary F. Bithell, Shauna West, Rona M. Cutler, Gillian McCluskey, Graham Craggs, Asher Maroof, Nicholas M. Barnes, David P. Humphreys, Stephen Rapecki, Bryan John Smith, Anthony Shock   +12 more
openalex   +1 more source

FcRn — not just for the kids [PDF]

Nature Reviews Immunology, 2011
openaire   +1 more source

Recombinant Human IgG1-Hexamer Reduces Pathogenic Autoantibodies in the K/BxN Mouse Model of Arthritis Independent of FcRn. [PDF]

Int J Mol Sci
Lewis BJB, Almizraq RJ, Cen S, Binnington B, Frias Boligan K, Spirig R, Käsermann F, Dunn SE, Branch DR.   +8 more
europepmc   +1 more source

Fc fragment of IgG receptor transporter-α (FCGRT; FCRN) [PDF]

, 2014

openalex   +1 more source

Monovalent antibody treatment of von Willebrand disease. [PDF]

Blood Adv
O'Donnell JS.
europepmc   +1 more source

OP0041 Treatment of primary Sjögren's disease by blocking FcRn: clinical and translational data from RHO, a phase 2 randomized, placebo controlled, double-blind, proof-of-concept study with efgartigimod

Isabelle Peene, Gwenny M. Verstappen, Joke Deprez, Frans G. M. Kroese, S. Arends, Aaron S. Kelly, L. Vandersarren, E Frances Bowen, Johannes W. G. Jacobs, Paul Meyvisch, Dirk Elewaut, Hendrika Bootsma   +11 more
openalex   +1 more source

Recurrent steroid-intolerant Hashimoto's encephalopathy responsive to single-dose neonatal Fc receptor antagonist: a case report and literature review. [PDF]

BMC Neurol
Wang X, Wang G, Xu J, Bai Y, Yan W, Liu X, Zhang S, Shen R.   +7 more
europepmc   +1 more source

FcRn mediated IgG transport by retinal pigment epithelium cells [PDF]

, 2012
Jeroen Bastiaans, Kiki van Bilsen, Marion Kolijn, Martin van Hagen, Nicoline M Korthagen, Robert W Kuijpers, Willem A Dik   +6 more
core   +1 more source

P049 Investigation into the binding affinity of certolizumab pegol to FcRn and functional consequences for FcRn-mediated transcytosis: comparison to infliximab, adalimumab and etanercept [PDF]

, 2014
Terry Baker, Lara Kevorkian, Andrew Nesbitt   +2 more
openalex   +1 more source

Oral FcRn-targeted insulin: Challenges and current strategies

Ava Aghakhani, Farbod Bahreini, Vladimir N. Uversky, Nima Rezaei   +3 more
openalex   +1 more source